DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 075493
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 075493 describes VINCRISTINE SULFATE PFS, which is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs. It is available from one supplier. Additional details are available on the VINCRISTINE SULFATE PFS profile page.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vincristine sulfate profile page.
Summary for 075493
| Tradename: | VINCRISTINE SULFATE PFS |
| Applicant: | Teva Pharms Usa |
| Ingredient: | vincristine sulfate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 075493
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Sep 1, 1999 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
